Mannose-Binding Lectin Gene Polymorphisms in Infants with Bronchiolitis and Post-Bronchiolitis Wheezing  by Nuolivirta, Kirsi et al.
Allergology International Vol 61, No2, 2012 www.jsaweb.jp 305
Mannose-Binding Lectin Gene
Polymorphisms in Infants with
Bronchiolitis and Post-Bronchiolitis
Wheezing
Kirsi Nuolivirta1, Qiushui He2, Kirsi Gröndahl-Yli-Hannuksela2, Petri Koponen3,
Matti Korppi3 and Merja Helminen3
ABSTRACT
Background: Mannose-binding lectin (MBL) encoded by the MBL2 gene, is an important component of the
innate immunity. Low levels have been linked with respiratory infections and both high and low levels with al-
lergy and asthma. The aims of the study were to evaluate the connection between polymorphisms of the MBL2
gene and viral findings, clinical characteristics and subsequent wheezing in young infants with bronchiolitis.
Methods: In all, 129 full-term infants hospitalized for bronchiolitis at age less than 6 months have been
followed-up until the mean age of 1.5 years. The genotyping of the MBL2 gene mutations was made by pyrose-
quencing for a simultaneous detection of three single nucleotide polymorphisms (SNP).
Results: The MBL genotypes or allele frequencies had no significant associations with clinical characteristics
of bronchiolitis. The 41 children with variant genotypes were more often infected by multiple viruses (21.9%, p
= 0.047) than children with wild-type AA genotypes (9.1%). In addition, more children with variant genotypes
(31.7%, p = 0.016) had used corticosteroids because of post-bronchiolitis wheezing, compared to those with
wild-type AA genotypes (13.6%). No other significant associations with viral findings or post-bronchiolitis out-
comes were found.
Conclusions: Preliminary evidence was found that the variant non-AA genotypes may be associated with
susceptibility to multiple viral infections and more severe post-bronchiolitis wheezing requiring treatment with
corticosteroids.
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INTRODUCTION
Mannose-binding lectin (MBL), encoded by the
MBL2 gene, plays a central role in the innate immu-
nity, which is important in early infancy before an es-
tablishment of adaptive immunity. MBL responds as
an acute-phase reactant and promotes phagocytosis
directly and via the lectin complement pathway.1
MBL deficiency due to mutations in the MBL gene is
rather common and seems to predispose to respira-
tory infections.2-4 However, data on the association
with asthma and allergy in children are conflicting.5-7
The results vary from no association withMBL2 gene
polymorphisms and asthma or atopy6,7 to significant
association.5 Low serum MBL levels have been asso-
ciated with single nucleotide polymorphisms (SNP)
in the MBL structural gene coding region and in the
promoter regions.1
Point mutations in exon 1 of MBL structural gene,
designated as dominant B, C, and D alleles, lead to
lowered serum MBL levels. The wild-type allele is re-
ferred to as A with variants commonly designated col-
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lectively as O. Wild-type homozygotes are referred to
as AA, those heterozygous for a coding mutation as
AO and those homozygous or compound heterozy-
gous as OO.8
We have prospectively enrolled and followed-up a
group of children hospitalized for bronchiolitis at age
less than 6 months.9,10 Our recent studies have pro-
vided preliminary evidence that polymorphisms of IL-
10, IFNG and TLR4 genes may have a significant as-
sociation with the aetiology, number and presenta-
tions of early-life respiratory infections.10,11
The aim of the present study was to evaluate
whether the polymorphisms of the MBL2 gene asso-
ciate with the presence, characteristics and viral aeti-
ology of bronchiolitis in early infancy. In addition, we
evaluated if there are any associations between the
polymorphisms and post-bronchiolitis outcomes in-
cluding subsequent infections, use of antibiotics, sub-
sequent wheezing and need of corticosteroid treat-
ments by 1.5 years of age.
METHODS
Previously healthy, full-term infants hospitalized for
bronchiolitis at less than 6 months of age between
December 1, 2001 and May 31, 2002 and between Oc-
tober 28, 2002 and May 31, 2004 were enrolled in the
study. Bronchiolitis was defined as an acute lower
respiratory illness characterized by rhinorrhea,
cough, and diffuse wheezes and crackles.12 The mi-
crobial aetiology of bronchiolitis was studied with an-
tigen detection assays and polymerase chain reac-
tions as described recently.9,10 Data on disease sever-
ity like the need of additional oxygen, feeding support
and length of hospital stay were recorded during the
inpatient care.9 One hundred and thirty-nine children
were invited to a follow-up visit at on average 18
months of age, and 129 (92.8%) attended.11 At the
follow-up visit, the parents were interviewed and a
questionnaire on the presence of otitis media, the use
of antibiotics and the presence of wheezing, repeated
wheezing and use of corticosteroids for wheezing af-
ter hospitalization for bronchiolitis, was fulfilled.11
The corticosteroid treatment included peroral steroid
courses as well as maintenance treatment with in-
haled corticosteroid. Repeated wheezing was defined
when there were 2 or more wheezing episodes dur-
ing follow-up time. Fresh or frozen whole blood sam-
ples were available for MBL genotyping from all 129
children. The Ethics Committee of the Tampere Uni-
versity Hospital District approved the study. In-
formed consent was obtained from parents before en-
rolling the children.
GENOTYPING OFMBL2 GENE POLYMORPHISM
The genotyping of MBL2 gene mutations was per-
formed with pyrosequencing for simultaneous detec-
tion of three SNPs in codons 52, 54 and 57. In short:
the genomic DNA was purified from peripheral blood
with Qiagen QiAmp DNA Blood Mini Kit 250
(Qiagen, Hilden, Germany) according to the instruc-
tions of the manufacturer. Five microliters of isolated
DNA were used for the amplification of the first exon
of the MBL2 gene by PCR. The PCR product was
used for pyrosequencing described by Roos et al..13
Sequential addition of NTP was used in the following
order: CTCTGTGTCATCACAGC. The reaction was
performed at 28℃. The close proximity of three func-
tionally important SNPs in exon 1 of the MBL2 gene
allows their detection in a single pyrosequencing re-
action. This procedure resulted in pyrograms with
unique and easily identified patterns for each allele
combination of the threeMBL2 SNPs.
STATISTICAL ANALYSES
Data were analysed by the SPSS package version 19.0
(IBM Corp. NY, USA). Chi-square and Fisher’s exact
tests were used for categorized and student’s t-test
for normally distributed and Mann-Whitney test for
non-normally distributed continuous variables. The
results are expressed as frequencies, proportional fre-
quencies, means, medians and standard deviations
(SD).
The personal data of the study subject were not
given to the laboratory which performed the genetic
studies (National Institute of Health and Welfare,
Turku, Finland).
RESULTS
Two-thirds (68%) of the 129 patients had the AA
genotype, 29% had AO and 3% had the OO geno-
type. The A allele, as either homozygous or heterozy-
gous, was present in nearly all (97%) children (Table
1). Thus, the A allele comprised 83% of all the 258 al-
leles. The respective figures were 10%, 0.4% and 6%
for the B, C, and D alleles. The MBL genotype AO
was associated with the presence of two or more viral
findings (Table 1). There were no other significant
associations between different MBL genotypes and
viral findings.
No significant associations were found between the
MBL genotypes and disease severity, need of supple-
mental oxygen, need of feeding support or length of
hospital stay (Table 2).
MBL2 genotype AO was associated with the need
of treatment with corticosteroids because of post-
bronchiolitis wheezing (Table 3). There were no
other significant associations between MBL genetics
and post-bronchiolitis outcomes.
DISCUSSION
There are two main results in the present study on
MBL2 gene polymorphisms in children hospitalized
for bronchiolitis in early infancy. First, the distribu-
tion of the three MBL genotypes AA (68%), AO
(29%) and OO (3%) was nearly identical with that in
the Finnish population, AA in 65%, AO in 30% and
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Table　1　MBL genetics in 129 children with bronchiolitis in relation to viral fi ndings
Genotypes and 
alleles
Total 
(N = 129)
Single RSV 
infections 
(N = 81)
Other single 
infections† 
(N = 17)
Two or more 
viruses‡ detected 
(N = 17)
No viruses 
detected 
(N = 14) 
Genotypes
AA 88 (68%) 60 (74%) 10 ( 59%) 8 ( 47%) 10 ( 71%) 
AO 37 (29%) 17 (21%) 7 ( 41%) 9 ( 53%)＊ 4 ( 29%)
OO 4 ( 3%) 4 ( 5%) 0 0 0
Alleles
A 125 (97%) 77 (95%) 17 (100%) 17 (100%) 14 (100%) 
B 27 (21%) 13 (16%) 6 ( 35%) 4 ( 24%) 4 ( 29%)
C 1 (0.8%) 0 1 (  6%) 0 0
D 15 (12%) 10 (13%) 0   5 ( 29%)＊＊ 0
† Rhinovirus (RV) in 9 cases, human metapneumovirus (hMPV) in 2 cases, infl uenza A virus (IVA) in 6 cases.
‡ RSV and RV in 6 cases, RSV and adenovirus in 3 cases, RSV and human bocavirus (hBoV) in 4 cases, RV and hBoV in 3 cases, IVA 
and adenovirus in 1 case.
* p = 0.047 vs. single infections; p = 0.034 vs. single RSV infections.
** p = 0.046 vs. single infections.
Table　2　The association between MBL genetics and basic and clinical characteristics of bronchiolitis patients
Patients (N = 129) Genotype AA (N = 88) (%)
Genotype AO or OO 
(N = 41) (%) p
All 
(N = 129) (%)
Age, weeks, median (range) 9.0 (1-25) 10.0 (2-25) 0.55 9.0 (1-25)
Boys 41 (47) 22 (54) 0.57 63 (49)
Oxygen required 18 (21) 5 (12) 0.33 23 (18)
Feeding support 27 (31) 17 (42) 0.24 44 (34)
Length of hospital stay, days, mean (SD, range) 4.6 (2.7, 0-12) 4.7 (3.9, 0-22) 0.22 4.6 (3.1, 0-22) 
Table　3　The association between MBL genetics and post-bronchiolitis outcomes by age 18 months
Patients (N = 129) Genotype AA (N = 88) (%)
Genotype AO or OO 
(N = 41) (%) p
History of antibiotic use 76 (86) 31 (76) 0.14
History of otitis media 72 (84) 30 (78) 0.46
Post-bronchiolitis wheezing 28 (32) 19 (46) 0.24
Repeated post-bronchiolitis wheezing 15 (17) 10 (24) 0.35
Use of corticosteroids 12 (14) 13 (32)† 0.016
† The genotype AO in 13 cases (allele B in 7 and D in 6 cases).
OO in 5%.14-16 Second, preliminary evidence was
found that the variant genotype AO in the present
study may be associated with multiple viral findings
and more severe post-bronchiolitis wheezing requir-
ing treatment with corticosteroids. There were no
other significant associations between MBL2 geno-
types or frequencies of single alleles and viral find-
ings, clinical characteristics or subsequent wheezing.
In line with our results, MBL deficiency and MBL2
genotypes were not associated with the need of hos-
pitalizations for RSV infections in a case-control study
in 168 infants from South Africa.17 In a study from
Brazil, however, 81 children less than 5 years old
with RSV infections had lower MBL levels than were
observed in 40 healthy controls, and in particular, pa-
tients with severe disease requiring hospitalization
had the lowest levels.18 In a prospective population-
based study from Greenland, 250 children aged less
than 2 years were followed-up weekly for 2 years, and
those who were heterozygous or homozygous for
variant alleles had an increased risk for acute respira-
tory infections, but not earlier than from the age of 6
months onwards.3 Several factors may explain the dif-
ferences between these studies, including disease se-
verity, infections by different viral strains or different
serotypes of the same virus, other concomitant infec-
tions and differences in MBL haplotypes which vary
worldwide.19 Our results offer preliminary evidence,
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that variant MBL genotypes may be associated with
viral co-infections in infants hospitalized for bron-
chiolitis at age less than 6 months.
Some studies have documented an association be-
tween MBL2 gene polymorphisms and repeated res-
piratory infections in children.20,21 MBL2 gene muta-
tions were more common in 335 Polish children with
recurrent respiratory infections, aged 1-16 years, than
in 78 age- and sex-matched healthy controls.20
Though coexisting immune defects were common,
presenting in 47% of the cases, MBL2 gene mutations
and low serum MBL levels were independent risk fac-
tors for recurrent infections. In a large population-
based study in non-selected, less than 6 years old
Chinese children, low serum MBL level and the pres-
ence of the B allele in the MBL2 gene were associ-
ated with recurrent respiratory infections.21 In the
present post-bronchiolitis study, no association was
found between MBL2 gene polymorphisms and the
presence of otitis media and the use of antibiotics un-
til 18 months of age; both parameters reflect the sus-
ceptibility to respiratory infections.
Data on the association between serums MBL level
or MBL gene polymorphisms and allergy or asthma
in children are conflicting.5-7 To our knowledge, there
are no previous studies focusing on bronchiolitis,
post-bronchiolitis wheezing or other early childhood
wheezing. The expectation is that high serum MBL
levels rather than low levels would be associated with
allergy, wheezing and asthma, as was seen in 72
Turkish schoolchildren with asthma compared with
30 healthy age- and sex-matched controls.5 One
MBL2 gene polymorphism associating with increased
serum MBL level, eosinophilia and asthma with aller-
gic rhinitis and bronchopulmonary aspergillosis has
been discovered.22 However, large population-based
studies made in blood donors, school children and
adults have failed to confirm any association between
MBL2 gene polymorphisms and asthma or al-
lergy.6,7,16,23,24
As part of a birth cohort study from UK, serum
MBL levels were measured in 124 Caucasian and 30
Asian children with a mean age of 10 years, and MBL
levels did not differ between atopic and non-atopic
children or between wheezing and non-wheezing
children.25 In wheezing children, however, MBL lev-
els were associated with the severity of wheezing as-
sessed by the required treatment; serum MBL was
higher in children treated with inhaled corticoster-
oids compared with non-treated wheezing children
and with healthy children.25 Though there was no as-
sociation between MBL2 gene polymorphisms and
clinical characteristics or disease severity of bron-
chiolitis in young infants, we found some evidence
that the variant non-AA MBL genotype may be associ-
ated with severe post-bronchiolitis wheezing requir-
ing treatment with corticosteroids. The post-
bronchiolitis use of corticosteroids offers also indirect
evidence for the presence of repeated wheezing.
These observations may reflect long-term or chronic
airway inflammation or only vulnerability to repeated
infections as well.
The main strengths of the present study are the
prospective design, an extensive virological testing
panel including RSV, rhinoviruses, metapneumovirus
and bocavirus, and the homogeneity of the patients
consisting of young Finnish infants hospitalized for
bronchiolitis at less than 6 months of age. A short-
coming of the study is the lack of data on serum MBL
concentrations. However, serum MBL concentrations
have been associated rather constantly with MBL
genotypes; when compared to subjects with the AA
genotype, those with the variant AO genotype have
presented with lowered concentrations and those
with the variant OO genotype with very low concen-
trations.8 Another shortcoming is the number of
cases which is small for genetic studies. In addition,
no healthy controls were recruited. However, the dis-
tribution of MBL genotypes and different alleles is
well studied in the Finnish population, which is, as is
well-known, still rather homogenous.
In conclusion, preliminary evidence was found that
in young infants hospitalized for bronchiolitis, variant
non-AA MBL genotypes may be associated with sus-
ceptibility to multiple viral infections and repeated or
severe post-bronchiolitis wheezing.
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